Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by Str8Shuteron Dec 10, 2021 5:44pm
231 Views
Post# 34220544

SZLS News: New Auditors Announced

SZLS News: New Auditors AnnouncedThese guys sure love their Friday evening controversial news releases, don't they? 

Accesswire: SZLS Appointment of SRCO as Auditors 

TORONTO, ON and RICHMOND, VA / ACCESSWIRE / December 10, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced that it has engaged Richmond Hill based SRCO Professional Corporation ("SRCO") as its auditors. McGovern Hurley LLP has resigned as the Company's auditors.

The resignation of McGovern Hurley and the appointment of SRCO have been approved by the Board of Directors of the Company. There are no reservations or modified opinion reports for the Company's financial reports audited by McGovern Hurley and there are no reportable events between the Company and McGovern Hurley.

SRCO Professional Corporation has offices in both Canada and the US. SRCO services companies with complex business operations similar to StageZero.

"We look forward to working with SRCO Professional Corporation as we prepare for a more robust US presence and we very much thank McGovern Hurley for their work during 2021 which was a pivotal year for us," said Matthew Pietras, CFO & COO of StageZero Life Sciences.

The Company will continue to work with MNP LLP, in assisting management with the preparation of its financial statements and integration of Care Oncology.

<< Previous
Bullboard Posts
Next >>